Octreotide and bromocriptine in patients with stage D2 prostate cancer who relapsed during treatment with flutamide and castration

Eur J Cancer. 1990;26(6):770-1. doi: 10.1016/0277-5379(90)90145-j.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bromocriptine / administration & dosage
  • Humans
  • Male
  • Octreotide / administration & dosage
  • Prostatic Neoplasms / drug therapy*

Substances

  • Bromocriptine
  • Octreotide